Recently in breast cancer, some naturally occurring alternative transcripts of BRCA1 and BRCA2, through mutational variants in the splicing sites, have been found to encode protein isoforms with residual tumor suppressive activity [13]. The gene discussed is BRCA1; the disease is breast cancer.